MANKIND PHARMA
|
The Current P/E Ratio of MANKIND PHARMA is 48.46.
Share Price | ₹2,352.4 | Jun 17,2025 |
Market Cap | ₹97,083.5 Cr | |
Earnings-TTM | ₹2,003.2 Cr | TTM-Consolidated Results |
Price/Earnings | 48.46x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of MANKIND PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹97,083.5 Cr] as on Jun 17,2025
(/) Earnings [ ₹2,003.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 48.46x ]
Thus, for MANKIND PHARMA , the investors are currently willing to pay 48.46 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MANKIND PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MANKIND PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of MANKIND PHARMA
PE Ratio Performance Analysis for MANKIND PHARMA
- MANKIND PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 9.62x.
- MANKIND PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/e ratio peaked in Mar2024 at 48.11x.
- MANKIND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does MANKIND PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
MANKIND PHARMA | 2,003.22 | 48.46 | 97,083.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.03 | 395,614.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 79.20 | 173,533.0 |
CIPLA LTD | 5,291.05 | 22.95 | 121,439.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 57.60 | 110,066.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 19.30 | 110,076.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.91 | 96,487.8 |
LUPIN LTD | 3,306.26 | 26.84 | 88,756.5 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.33 | 64,439.9 |
ABBOTT INDIA LTD | 1,414.44 | 47.78 | 67,579.9 |
ALKEM LABORATORIES LTD | 2,216.00 | 25.97 | 57,542.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MANKIND PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.33x |
Max industry PE | 79.20x |
Median industry PE | 26.84x |
Average industry PE | 36.67x |
You may also like the below Video Courses